Skip to main content
. 2021 Sep 15;11:18345. doi: 10.1038/s41598-021-97869-1

Figure 5.

Figure 5

DCFDA staining of CSE-treated, SCAL1-deficient and SCAL1-overexpressing A549 cells to assess production of reactive oxygen species (Olympus IX51, ×100, FITC: 500 ms). (a,b) The fluorescein-based dye DCFDA exhibits green fluorescence upon oxidation by ROS. The bright green signal observed in A549 cells signifies ROS production. DCFDA intensities normalized against cell count showed increased mean ROS production upon SCAL1 knockdown. (c,d) DCFDA fluorescence signals were lower in the SCAL1 overexpression setup, suggesting that increased SCAL1 levels decrease ROS production. Data presented are representative of three independent trials performed in triplicates and are expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.